Keloid Scar Following SurgeryNCT06806735
Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry
An observational study of Keloid Scar Following Surgery and Scars, Hypertrophic, run by University of Zurich at 1 site in Switzerland.
Trial summary
Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Keloid Scar Following Surgery, Scars, Hypertrophic, Scar Keloid
- What is being tested?
- 3D-Pictures
- How many people
- 20 participants
- Where
- 1 siteSwitzerland
- Study dates
- 10 Jan 2025to 30 Sep 2025
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with hypertrophic scars or keloids of the University Hospital Zurich
Who may be able to join
- All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years.
Who cannot join
- Absence of written consent, unwillingness to contribute data, inability to understand the study protocol.
- lack of hypertrophic scars or keloid
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Switzerland1 site, 1 recruiting
- Recruiting
Universitätsspital Zürich
Zurich, Canton of Zurich, 8091
Michael Prof. Dr. med. Soyka, +41 44 255 58 33, rhinologie@usz.ch
About this study
Official title: Quantification of Hypertrophic Scar Tissue or Keloid Using a 3D-Camera
Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry.
Read the detailed description
The objective of this study is to utilize a 3D camera to measure the volumes of hypertrophic scars and keloids in patients at specified time points. The time points for measurement include day 0, as well as 3, 6, and 12 months. The 3D camera will be evaluated for their efficacy in measuring and documenting the volumes of the scars. This evaluation will include volumetry, which is the measurement of the three-dimensional space occupied by an object.
- Being tested
- 3D-Pictures
- Medical subject headings
- Cicatrix, Hypertrophic, Keloid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
3D-PicturesOther
3D-Pictures will be taken of hypertrophic scars and keloids to document them.
What is being measured
The primary outcome is the main question the study is designed to answer.
Measurability
The objective of this study is to determine the feasibility of utilizing 3D cameras to accurately measure hypertrophic scars and keloids. The primary outcome of this study is the measurement of the volumes of hypertrophic scars in cubic millimeters (equivalent to milliliters) over a period of one year. This will allow for an evaluation of the accuracy of 3D photography and for the observation of any potential changes.
Measured: Day 0, Month 3, 6 and 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Feb 2025
- Study start10 Jan 2025
- Primary completion30 Sep 2025 (estimated)
- Study completion30 Sep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Keloid Scar Following SurgeryStudies of the same condition, open and under way.
- More trials run by University of ZurichThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- University of Zurich
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06806735
- Sponsor's protocol ID
- 2024-01147
- Status last verified
- Feb 2025
- First submitted
- 21 Jan 2025
- Last updated
- 7 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Quantification of Hypertrophic Scar Tissue or Keloid Using a 3D-Camera
- ClinicalTrials.gov ID
- NCT06806735
- Acronym / sponsor ID
- 2024-01147
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- University of ZurichUniversity, hospital or other
- Study start
- 10 Jan 2025 (actual)
- Primary completion
- 30 Sep 2025 (estimated)
- Study completion
- 30 Sep 2025 (estimated)
- First posted
- 4 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry.
Detailed description
The objective of this study is to utilize a 3D camera to measure the volumes of hypertrophic scars and keloids in patients at specified time points. The time points for measurement include day 0, as well as 3, 6, and 12 months. The 3D camera will be evaluated for their efficacy in measuring and documenting the volumes of the scars. This evaluation will include volumetry, which is the measurement of the three-dimensional space occupied by an object.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with hypertrophic scars or keloids of the University Hospital Zurich
Key inclusion criteria (1 listed)
- All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years.
Key exclusion criteria (2 listed)
- Absence of written consent, unwillingness to contribute data, inability to understand the study protocol.
- lack of hypertrophic scars or keloid
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 3D-Pictures3D-Pictures will be taken of hypertrophic scars and keloids to document them. | Other | – |
Primary outcome
Measurability
Time frame: Day 0, Month 3, 6 and 12
The objective of this study is to determine the feasibility of utilizing 3D cameras to accurately measure hypertrophic scars and keloids. The primary outcome of this study is the measurement of the volumes of hypertrophic scars in cubic millimeters (equivalent to milliliters) over a period of one year. This will allow for an evaluation of the accuracy of 3D photography and for the observation of any potential changes.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Feb 2025.
Related trials for Keloid Scar Following Surgery
Enrolling by invitation
Preoperative Silicone Ointment and Wound Healing
Wound Heal, Scar
Not yet recruitingPhase 3
Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact
Sternotomy Closure,Open Heart Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Keloid Scar Following Surgery and Scars, Hypertrophic, run by University of Zurich at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Prof. Dr. med. Soyka (+41 44 255 58 33, rhinologie@usz.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Measurability (time frame: Day 0, Month 3, 6 and 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2025.